Singapore markets close in 5 hours 17 minutes
Straits Times Index
3,308.02 +11.13 (+0.34%) Nikkei
38,236.07 -37.98 (-0.10%) Hang Seng
18,400.64 +193.51 (+1.06%) FTSE 100
8,172.15 +50.91 (+0.63%) Bitcoin USD
59,759.41 +2,263.20 (+3.94%) CMC Crypto 200
1,287.89 +17.15 (+1.35%)
Intellia Therapeutics, Inc. (NTLA)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 22.50 |
| Open | 22.80 |
| Bid | 23.24 x 1000 |
| Ask | 23.31 x 1000 |
| Day's range | 22.37 - 23.36 |
| 52-week range | 19.37 - 47.48 |
| Volume | |
| Avg. volume | 1,483,719 |
| Market cap | 2.244B |
| Beta (5Y monthly) | 1.80 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Intellia (NTLA) to Report Q1 Earnings: What's in the Cards?
On Intellia's (NTLA) first-quarter 2024 earnings call, investors' focus is likely to be on the progress of its pipeline of genome-editing candidates.
- Zacks
Earnings Preview: Intellia Therapeutics, Inc. (NTLA) Q1 Earnings Expected to Decline
Intellia Therapeutics (NTLA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Simply Wall St.
Intellia Therapeutics (NASDAQ:NTLA shareholders incur further losses as stock declines 9.9% this week, taking three-year losses to 65%
Investing in stocks inevitably means buying into some companies that perform poorly. But the long term shareholders of...
© 2024 Yahoo. All rights reserved.